CN113747946B - 黄病毒感染症治疗剂 - Google Patents

黄病毒感染症治疗剂 Download PDF

Info

Publication number
CN113747946B
CN113747946B CN202080031534.4A CN202080031534A CN113747946B CN 113747946 B CN113747946 B CN 113747946B CN 202080031534 A CN202080031534 A CN 202080031534A CN 113747946 B CN113747946 B CN 113747946B
Authority
CN
China
Prior art keywords
ala
infection
virus
flavivirus
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN202080031534.4A
Other languages
English (en)
Chinese (zh)
Other versions
CN113747946A (zh
Inventor
增田道明
石川知弘
河田聪史
富冈基康
和田康史
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
School Legal Person Independent Association School Park Independent Association Medical University
Newao Pharmaceutical Co ltd
Original Assignee
School Legal Person Independent Association School Park Independent Association Medical University
Newao Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by School Legal Person Independent Association School Park Independent Association Medical University, Newao Pharmaceutical Co ltd filed Critical School Legal Person Independent Association School Park Independent Association Medical University
Publication of CN113747946A publication Critical patent/CN113747946A/zh
Application granted granted Critical
Publication of CN113747946B publication Critical patent/CN113747946B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN202080031534.4A 2019-04-26 2020-04-24 黄病毒感染症治疗剂 Expired - Fee Related CN113747946B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2019-086554 2019-04-26
JP2019086554 2019-04-26
PCT/JP2020/017837 WO2020218577A1 (ja) 2019-04-26 2020-04-24 フラビウイルス感染症治療剤

Publications (2)

Publication Number Publication Date
CN113747946A CN113747946A (zh) 2021-12-03
CN113747946B true CN113747946B (zh) 2023-08-29

Family

ID=72942078

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080031534.4A Expired - Fee Related CN113747946B (zh) 2019-04-26 2020-04-24 黄病毒感染症治疗剂

Country Status (6)

Country Link
US (1) US20220193124A1 (https=)
EP (1) EP3960241A4 (https=)
JP (1) JPWO2020218577A1 (https=)
CN (1) CN113747946B (https=)
TW (1) TW202106293A (https=)
WO (1) WO2020218577A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7497790B2 (ja) * 2019-12-27 2024-06-11 国立大学法人北海道大学 豚コレラの治療及び／又は予防剤
JPWO2021215517A1 (https=) * 2020-04-22 2021-10-28

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5895786A (en) * 1996-05-08 1999-04-20 New York Blood Center, Inc. Method for treating viral infections
JP4417865B2 (ja) 2004-03-30 2010-02-17 コスモ石油株式会社 ５−アミノレブリン酸リン酸塩、その製造方法及びその用途
JP4520219B2 (ja) 2004-05-28 2010-08-04 協和発酵バイオ株式会社 ５−アミノレブリン酸の製造法
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
WO2011003071A1 (en) * 2009-07-02 2011-01-06 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods of modulating hepatitis c virus infection
WO2014013664A1 (ja) 2012-07-19 2014-01-23 Ｓｂｉファーマ株式会社 インフルエンザウイルス感染症の予防・治療剤
HK1246682A1 (en) 2015-04-10 2018-09-14 Sbi Pharmaceuticals Co., Ltd. Prophylactic/therapeutic agent for virus infections which comprises ala compound
WO2019059027A1 (ja) * 2017-09-19 2019-03-28 ネオファーマジャパン株式会社 ５－アミノレブリン酸を含むエビ目用組成物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Dynamics of absorption, metabolism, and excretion of 5-aminolevulinic acid in human intestinal Caco-2 cells;Saito.K,et al;《Biochemistry and Biophysics Reports》;20171231;第11卷;第105-111页 *

Also Published As

Publication number Publication date
EP3960241A4 (en) 2023-06-07
US20220193124A1 (en) 2022-06-23
JPWO2020218577A1 (https=) 2020-10-29
EP3960241A1 (en) 2022-03-02
WO2020218577A1 (ja) 2020-10-29
TW202106293A (zh) 2021-02-16
CN113747946A (zh) 2021-12-03

Similar Documents

Publication Publication Date Title
CN102151256B (zh) 原儿茶酸在制备防治畜禽病毒感染性疾病的药物中的应用
AU2021205039B2 (en) Method of viral inhibition
CN113747946B (zh) 黄病毒感染症治疗剂
WO2016163082A1 (ja) Ａｌａ類を含むウイルス感染症予防／治療剤
US20260007649A1 (en) Methods and compositions for the antiviral use of synthetic lysine analogs and mimetics
Stefanou et al. Pomegranate as an anti-viral agent and immune system stimulant
CN103349776A (zh) 一种依达拉奉注射液及其制备方法
WO2021244481A1 (en) Compositions and methods for treating a sars-cov-2 infection
KR20240110039A (ko) SARS-CoV-2 감염을 치료하는 방법
WO2007106675A2 (en) Composition and method of retarding viral activity and reducing viral replication
CN108014129A (zh) 铁离子在抑制rna病毒中的应用
WO2021227540A1 (zh) 一种补益人体元气的保健器
WO2020099696A1 (es) Uso de ésteres derivados del ácido gálico como antivirales
EP4275683A1 (en) Antiviral pharmaceutical composition comprising steroid sulfatase inhibitor
US7282599B2 (en) Dithiocarbamate antiviral agents and methods of using same
WO2024027844A1 (zh) 一种药物组合物及其用途
CN117919378A (zh) 一种版纳绳蚋宿主防御肽Siba3的应用
CN118717804A (zh) 锌在防治传染性脾肾坏死病毒感染中的应用
WO2021228714A1 (en) Antiviral composition comprising eeyarestatin i
CN118436625A (zh) 预防和/或治疗脑缺血的药物和/或保健品
CN111632146A (zh) Oat抑制剂和溶瘤病毒在制备抗肿瘤药物中的应用
WO2020216349A1 (zh) 一种肠道病毒抑制剂

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20230829